(0.19%) 5 141.00 points
(0.16%) 38 504 points
(0.26%) 17 892 points
(-0.87%) $83.12
(1.61%) $1.954
(-0.17%) $2 343.20
(0.89%) $27.50
(0.25%) $924.40
(-0.18%) $0.933
(-0.13%) $11.01
(-0.24%) $0.798
(1.18%) $92.96
Live Chart Being Loaded With Signals
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services and solutions in life sciences and supply chain management in the United States, the Asia Pacific, and Europe...
Stats | |
---|---|
Šios dienos apimtis | 92 961.00 |
Vidutinė apimtis | 786 683 |
Rinkos kapitalizacija | 3.47B |
EPS | INR0 ( 2024-02-12 ) |
Kita pelno data | ( INR0 ) 2024-05-27 |
Last Dividend | INR0.400 ( 2019-08-01 ) |
Next Dividend | INR0 ( N/A ) |
P/E | -23.69 |
ATR14 | INR0.0620 (0.26%) |
Tūris Koreliacija
TAKE Solutions Limited Koreliacija
10 Labiausiai teigiamai susiję koreliacijos |
---|
10 Labiausiai neigiamai susiję koreliacijos |
---|
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
TAKE Solutions Limited Koreliacija - Valiuta/Žaliavos
TAKE Solutions Limited Finansinės ataskaitos
Annual | 2022 |
Pajamos: | INR1.89B |
Bruto pelnas: | INR1.06B (56.10 %) |
EPS: | INR-6.86 |
FY | 2022 |
Pajamos: | INR1.89B |
Bruto pelnas: | INR1.06B (56.10 %) |
EPS: | INR-6.86 |
FY | 2022 |
Pajamos: | INR6.55B |
Bruto pelnas: | INR4.61B (70.38 %) |
EPS: | INR-6.08 |
FY | 2021 |
Pajamos: | INR7.74B |
Bruto pelnas: | INR5.86B (75.70 %) |
EPS: | INR-30.91 |
Financial Reports:
No articles found.
TAKE Solutions Limited Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
INR0 (N/A) |
First Dividend | INR0.200 | 2008-07-30 |
Last Dividend | INR0.400 | 2019-08-01 |
Next Dividend | INR0 | N/A |
Payout Date | 2019-09-06 | |
Next Payout Date | N/A | |
# dividends | 26 | -- |
Total Paid Out | INR9.80 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 1.26 | -- |
Div. Sustainability Score | 0 | |
Div.Growth Potential Score | 1.050 | |
Div. Directional Score | 0 | -- |
Year | Amount | Yield |
---|---|---|
2008 | INR0 | 0.00% |
2009 | INR0 | 0.00% |
2010 | INR0 | 0.00% |
2011 | INR0 | 0.00% |
2012 | INR0 | 0.00% |
2013 | INR0 | 0.00% |
2014 | INR0 | 0.00% |
2015 | INR0 | 0.00% |
2016 | INR0 | 0.00% |
2017 | INR0 | 0.00% |
2018 | INR1.200 | 0.55% |
2019 | INR0.700 | 0.47% |
2020 | INR0 | 0.00% |
2021 | INR0 | 0.00% |
2022 | INR0 | 0.00% |
2023 | INR0 | 0.00% |
2024 | INR0 | 0.00% |
The company does not currently pay dividends. Given its current dividend status and a low Dividend Growth Potential Score (DGPS), there's minimal likelihood of dividends being initiated soon. Considering all factors, the near-term dividend outlook for the company remains unpromising.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
RITES.NS | Dividend Knight | 2023-09-08 | Quarterly | 7 | 3.95% | |
LAMBODHARA.NS | Dividend Junior | 2023-09-14 | Annually | 10 | 0.87% | |
FORCEMOT.NS | Dividend Junior | 2023-09-21 | Annually | 6 | 0.45% | |
APLAPOLLO.NS | Ex Dividend Junior | 2023-09-01 | Sporadic | 13 | 0.07% | |
TATVA.NS | Dividend Junior | 2023-09-08 | Annually | 3 | 0.04% | |
NUCLEUS.NS | Dividend Junior | 2023-07-07 | Annually | 22 | 1.41% | |
INDUSINDBK.NS | Dividend Junior | 2023-06-02 | Annually | 23 | 0.56% | |
COLPAL.NS | Dividend Knight | 2023-05-19 | Semi-Annually | 18 | 1.38% | |
SBIN.NS | Dividend Junior | 2023-05-31 | Sporadic | 29 | 0.99% | |
MAHSEAMLES.NS | Dividend Junior | 2023-08-14 | Annually | 21 | 0.80% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.762 | 1.500 | -10.00 | -10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0 | 1.200 | 0 | 0 | [0 - 0.3] |
returnOnEquityTTM | -0.616 | 1.500 | -7.95 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 0 | 0.800 | -5.00 | -4.00 | [1 - 3] |
quickRatioTTM | 0 | 0.800 | -4.71 | -3.76 | [0.8 - 2.5] |
cashRatioTTM | 0 | 1.500 | -1.111 | -1.667 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | -0.576 | 1.000 | -1.324 | -1.324 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.338 | 2.00 | 9.55 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.861 | 2.00 | 9.57 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.491 | 1.000 | 5.15 | 5.15 | [0.2 - 0.8] |
operatingProfitMarginTTM | -0.0485 | 1.000 | -2.97 | -2.97 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0 | 0.800 | -3.33 | -2.67 | [0.5 - 2] |
Total Score | -1.635 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -5.33 | 1.000 | -0.639 | 0 | [1 - 100] |
returnOnEquityTTM | -0.616 | 2.50 | -5.11 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.861 | 2.00 | 9.71 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.338 | 2.00 | 9.55 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | -0.0611 | 1.500 | -3.74 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.230 | 1.000 | 6.75 | 0 | [0.1 - 0.5] |
Total Score | 1.050 |
TAKE Solutions Limited
TAKE Solutions Limited, together with its subsidiaries, provides domain-intensive services and solutions in life sciences and supply chain management in the United States, the Asia Pacific, and Europe. The company offers IP-driven and technology backed solutions, consulting, and functional services across clinical, regulatory, and safety for life sciences industry. It also provides clinical research, generics development, data sciences, regulatory affairs, and pharmacovigilance/safety services. In addition, the company provides IT infrastructure and support, supply chain management, engineering, designing, and sourcing services. It serves to large and small innovator biopharmaceutical and devices companies, as well as generics manufacturers. The company was incorporated in 2000 and is headquartered in Chennai, India. TAKE Solutions Limited is a subsidiary of TAKE Solutions Pte. Limited.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.